BK Polyomavirus MicroRNA Levels in Exosomes Are Modulated by Non-Coding Control Region Activity and Down-Regulate Viral Replication When Delivered to Non-Infected Cells Prior to Infection.
-
Martelli F
Department of Experimental and Clinical Medicine, University of Florence, I-50134 Florence, Italy. martelli.francesco85@gmail.com.
-
Wu Z
Transplantation & Clinical Virology, Department Biomedicine (Haus Petersplatz), University of Basel, CH-4003 Basel, Switzerland. zongsong.wu@unibas.ch.
-
Delbue S
Department of Biomedical, Surgical and Dental Sciences, University of Milan, I-20100 Milano, Italy. serena.delbue@unimi.it.
-
Weissbach FH
Transplantation & Clinical Virology, Department Biomedicine (Haus Petersplatz), University of Basel, CH-4003 Basel, Switzerland. fabian.weissbach@unibas.ch.
-
Giulioli MC
Department of Experimental and Clinical Medicine, University of Florence, I-50134 Florence, Italy. maria.chiara2591@gmail.com.
-
Ferrante P
Department of Biomedical, Surgical and Dental Sciences, University of Milan, I-20100 Milano, Italy. pasquale.ferrante@unimi.it.
-
Hirsch HH
Transplantation & Clinical Virology, Department Biomedicine (Haus Petersplatz), University of Basel, CH-4003 Basel, Switzerland. hans.hirsch@unibas.ch.
-
Giannecchini S
Department of Experimental and Clinical Medicine, University of Florence, I-50134 Florence, Italy. simone.giannecchini@unifi.it.
Show more…
English
In immunosuppressed patients, BKPyV-variants emerge carrying rearranged non-coding control-regions (rr-NCCRs) that increase early viral gene region (EVGR) expression and replication capacity. BKPyV also encodes microRNAs, which have been reported to downregulate EVGR-encoded large T-antigen transcripts, to decrease viral replication in infected cells and to be secreted in exosomes. To investigate the interplay of NCCR and microRNAs, we compared archetype- and rr-NCCR-BKPyV infection in cell culture. We found that laboratory and clinical rr-NCCR-BKPyV-strains show higher replication rates but significantly lower microRNA levels than archetype virus intracellularly and in exosomes. To investigate whether rr-NCCR or increased EVGR activity modulated microRNA levels, we examined the (sp1-4)NCCR-BKPyV, which has an archetype NCCR-architecture but shows increased EVGR expression due to point mutations inactivating one Sp1 binding site. We found that microRNA levels following (sp1-4)NCCR-BKPyV infection were as low as in rr-NCCR-variants. Thus, NCCR rearrangements are not required for lower miRNA levels. Accordingly, Sp1 siRNA knock-down decreased microRNA levels in archetype BKPyV infection but had no effect on (sp1-4)- or rr-NCCR-BKPyV. However, rr-NCCR-BKPyV replication was downregulated by exosome preparations carrying BKPyV-microRNA prior to infection. To explore the potential relevance in humans, urine samples from 12 natalizumab-treated multiple sclerosis patients were analysed. In 7 patients, rr-NCCR-BKPyV were detected showing high urine BKPyV loads but low microRNAs levels, whereas the opposite was seen in 5 patients with archetype BKPyV. We discuss the results in a dynamic model of BKPyV replication according to NCCR activity and exosome regulation, which integrates immune selection pressure, spread to new host cells and rr-NCCR emergence.
-
Language
-
-
Open access status
-
gold
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/global/documents/53976
Statistics
Document views: 22
File downloads: